Caribou Biosciences (CRBU) Net Equity Issued and Repurchased (2020 - 2026)
Caribou Biosciences' Net Equity Issued and Repurchased was $17.92 million in Q2 2026, up 707.8% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Caribou Biosciences' Net Equity Issued and Repurchased was $23.75 million through Jun 30, 2026, up 448.3% year-over-year; for FY2025, it was $4.07 million, down 73.2% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 72.0% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $15.19 million in FY2024 (-12.1%), $17.29 million in FY2023 and $321.02 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q3 2021.
- Per Business Quant data, CRBU's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $2.22 million (Q1 2026), $3.33 million (Q4 2025) and $277,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Caribou Biosciences | 59.36 Mn | -457.18 Mn | - | 17.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.94 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 277,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Mar 31, 2024 | 12.49 Mn |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 17.50 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 654,000.00 |
| Jun 30, 2022 | 362,000.00 |
| Mar 31, 2022 | 990,000.00 |
| Dec 31, 2021 | 460,000.00 |
| Sep 30, 2021 | 321.98 Mn |
API Access
Caribou Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();